You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 192 Clinicopathologic, genomic and immunophenotypic features and outcomes to immune checkpoint inhibitors in patients with mucinous lung adenocarcinoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
192 Clinicopathologic, genomic and immunophenotypic features and outcomes to immune checkpoint inhibitors in patients with mucinous lung adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202314606
Dec 20234705
Jan 20242201
Feb 20242804
Mar 20243609
Apr 20242404
May 20243201
Jun 20241202
Jul 2024602
Aug 20241602
Sep 20242208
Oct 20241204
Nov 20241206
Dec 2024205
Jan 20251606
Feb 2025806
Mar 2025006
Apr 2025108
May 2025009
Jun 2025103
Total443097